| Valuation method | Value, £ | Upside, % |
|---|---|---|
| Artificial intelligence (AI) | 241.40 | 726 |
| Intrinsic value (DCF) | 21.90 | -25 |
| Graham-Dodd Method | 18.90 | -35 |
| Graham Formula | 930.60 | 3083 |
Altamir SCA is a leading private equity firm based in Paris, France, specializing in direct and fund-of-fund investments across small and mid-cap companies. With a focus on middle-market buyouts and growth capital, Altamir targets underdeveloped divisions of larger corporations and invests in sectors such as healthcare, TMT, digital companies, services, retail, and distribution. The firm has a strong geographic focus on Europe, particularly France, Italy, and Benelux, while also exploring opportunities in North America and emerging markets like China, India, and Brazil. Altamir collaborates closely with Apax Partners France and Apax Partners LLC, leveraging their expertise to maximize returns. The firm typically seeks majority stakes or lead shareholder positions, with an investment horizon of around five years. Altamir’s diversified portfolio and strategic partnerships position it as a key player in the European private equity landscape, offering investors exposure to high-growth sectors and emerging market opportunities.
Altamir SCA presents an attractive investment opportunity for those seeking exposure to European private equity with a diversified sector focus. The firm’s collaboration with Apax Partners enhances its deal-sourcing and value-creation capabilities. However, risks include exposure to economic downturns in key markets and the illiquid nature of private equity investments. With a market cap of €1.03 billion and a beta of 0.416, Altamir offers lower volatility compared to broader equity markets. The firm’s revenue of €72.7 million and net income of €18.8 million in the latest fiscal year reflect steady performance, though the absence of dividends may deter income-focused investors. The firm’s strong cash position (€35.2 million) and manageable debt (€238.5 million) provide financial flexibility for future investments.
Altamir SCA’s competitive advantage lies in its strategic partnership with Apax Partners, which provides access to high-quality deal flow and operational expertise. The firm’s focus on middle-market buyouts and growth capital in Europe differentiates it from larger global private equity players. Altamir’s sector specialization, particularly in healthcare and TMT, allows it to identify niche opportunities with strong growth potential. However, the firm faces competition from other European private equity firms with similar strategies, such as Eurazeo and Ardian. Altamir’s ability to co-invest with Apax funds provides a unique edge, but its reliance on a single partner could also be a vulnerability. The firm’s disciplined investment approach and focus on value creation through operational improvements position it well in a competitive market, though its smaller scale compared to global giants like Blackstone or KKR limits its ability to compete for mega-deals.